Brainsway Ltd.

For the period ended Jun 30, 2026. Filed Sep 29, 2026.

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Jun 30, 2026 · Filed Sep 29, 2026

Use the contents to explore the available documents and sections.

BWAY$11.15+5.1%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.2 · Recent Developments

Recent Developments

Strategic Investments

We continued expanding our minority investment portfolio through strategic investments in Hopemark Health, Radial Health, BrainStim, and Active Recovery TMS, as well as a $6.0 million second-tranche convertible loan investment in Neurolief.

Remaining Performance Obligations

As of June 30, 2026, our remaining performance obligations grew 30% year-over-year to $80.4 million.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.